Erin R Rudzinski Selected Research

Mesoblastic Nephroma (Congenital Mesoblastic Nephroma)

3/2022	ALK rearrangements in infantile fibrosarcoma-like spindle cell tumours of soft tissue and kidney.
1/2022	Mesenchymal neoplasms with NTRK and other kinase gene alterations.
1/2018	Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erin R Rudzinski Research Topics

Disease

21	Neoplasms (Cancer) 10/2022 - 02/2013
6	Sarcoma (Soft Tissue Sarcoma) 03/2022 - 05/2014
5	Fibrosarcoma 10/2022 - 01/2018
5	Rhabdomyosarcoma 01/2021 - 02/2013
4	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2020
3	Mesoblastic Nephroma (Congenital Mesoblastic Nephroma) 03/2022 - 01/2018
3	Alveolar Rhabdomyosarcoma 01/2020 - 01/2013
3	Embryonal Rhabdomyosarcoma 01/2019 - 01/2013
2	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 01/2019
1	Long Term Adverse Effects 06/2022
1	Vascular Malformations 04/2022
1	Arteriovenous Malformations (Arteriovenous Malformation) 04/2022
1	Myofibroma 02/2022
1	Myofibromatosis 02/2022
1	Cytomegalovirus Infections (Inclusion Disease) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Disease Progression 10/2021
1	COVID-19 01/2021
1	Anaplasia 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Hemorrhage 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Vasculitis (Vasculitides) 01/2021
1	Asymptomatic Infections 01/2021
1	Nausea 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	medullary Thyroid cancer 01/2020
1	follicular Thyroid cancer 01/2019
1	Adamantinoma 01/2019
1	Medullary Carcinoma 01/2019
1	Residual Neoplasm 01/2019
1	Papillary Thyroid Cancer 01/2019
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 01/2019
1	Abdominal Pain (Pain, Abdominal) 12/2016
1	Fever (Fevers) 12/2016
1	Cysts 12/2016
1	Osteosarcoma (Osteogenic Sarcoma) 01/2015
1	Adenoma (Adenomas) 09/2007
1	Paraganglioma (Paragangliomas) 09/2007

Drug/Important Bio-Agent (IBA)

8	Phosphotransferases (Kinase)IBA 06/2022 - 01/2018
5	larotrectinibIBA 06/2022 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2014
3	MyogeninIBA 05/2014 - 01/2013
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2022 - 01/2022
2	TropomyosinIBA 06/2022 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 06/2022 - 11/2017
2	tyrosine receptor (receptor, tyrosine)IBA 06/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2013
2	AntibodiesIBA 01/2021 - 01/2018
2	Biological ProductsIBA 01/2019 - 01/2013
2	entinostat (MS 275)IBA 01/2019 - 11/2018
1	ErbB Receptors (EGF Receptor)IBA 10/2022
1	Mitogen-Activated Protein KinasesIBA 04/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2022
1	Imatinib Mesylate (Gleevec)FDA Link 02/2022
1	tazemetostatIBA 01/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2021
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	IodineIBA 01/2020
1	Keratins (Keratin)IBA 01/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Histone Deacetylase InhibitorsIBA 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2018
1	Vincristine (Oncovin)FDA LinkGeneric 01/2018
1	LigandsIBA 11/2017
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 12/2016
1	GD2 gangliosideIBA 01/2015
1	MyoD ProteinIBA 02/2013
1	ChromatinIBA 02/2013
1	Transcription Factors (Transcription Factor)IBA 02/2013
1	RadiopharmaceuticalsIBA 09/2007
1	MetanephrineIBA 09/2007
1	Epinephrine (Adrenaline)FDA LinkGeneric 09/2007
1	NormetanephrineIBA 09/2007
1	Vanilmandelic Acid (Vanillylmandelic Acid)IBA 09/2007
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 09/2007

Therapy/Procedure

7	Therapeutics 04/2022 - 01/2018
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
2	Radiotherapy 10/2021 - 01/2021
1	Surgical Amputation (Amputations) 06/2022
1	Combined Modality Therapy 01/2022
1	Neoadjuvant Therapy 01/2020
1	Adjuvant Radiotherapy 01/2020
1	Thyroidectomy 01/2019
1	Surgical Decompression 12/2016